INFOGRAPHIC: Sweden's Vibrant And Growing Life Sciences Landscape
Executive Summary
Sweden's life science industry is a key component of the Scandinavian country's economy. New life science companies emerge there every year. Growing shipments to China and Japan by Swedish companies reflect the duo’s increasing importance as export markets, especially in relation to the US and the European Union. And while the UK has hitherto been regarded as a stepping stone to foreign markets, worries over what Brexit will mean for future business and opportunities is prompting players to increasingly look to the US to set up operations.
You may also be interested in...
Anjarium To Pioneer Next-Generation Non-Viral Gene Therapies
Emerging Company Profile: Switzerland-based Anjarium Biosciences AG has successfully raised $61m in a series A financing that will fund expansion of its novel proprietary platform and development of a nascent pipeline of non-viral gene therapies.
Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval
Incyte welcomed FDA approval of its ruxolitinib cream, a selective JAK1/JAK2 inhibitor, as a treatment for atopic dermatitis, but criticized the boxed warnings label assigned to it.
BioPlx Says It Can Stop Recurrent MRSA Cycles In Hospitals
Emerging Company Profile: Privately held BioPlx is a US-based platform biotech that has successfully raised more than $10m from investors with the promise of developing non-antibiotic ways to control multiple-drug resistant superbugs and other infectious diseases.